| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±2.1% | -11.9% | under-priced |
| 05/06/2026 | ±2.2% | -2.5% | under-priced |
| 02/12/2026 | ±2.5% | -1.6% | over-priced |
| 11/05/2025 | ±2.3% | +1.9% | over-priced |
| 08/07/2025 | ±1.5% | -0.2% | over-priced |
| 05/08/2025 | ±1.7% | +7.0% | under-priced |
| 02/14/2025 | ±2.3% | +1.8% | over-priced |
| 11/07/2024 | ±2.3% | -5.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.73 | $6.4B | $1.2B |
| Q1 FY2026 | $1.07 | $4.9B | $720M |
| Q4 FY2025 | — | $3.9B | $-552M |
| Q3 FY2025 | $-0.47 | $2.6B | $-320M |
Corteva, Inc. Common Stock (CTVA) reports in 1 day, with the next report estimated for 10/28/2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 4.0% on average — the market has been roughly fair on CTVA's earnings risk. Fundamentals into the print: EPS down 9.9% year-over-year, revenue down 1.2%. QuantLogix's live 5-factor engine currently reads CTVA as a underweight at 40/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →